标准与讨论一器2022欧洲心脏病学会(ESC)肿瘤心脏病学指南一高血压相关内容解读2022 ESC Guidelines on Cardio-Oncology:Interpretation of Hypertension褚紫昕1，匡泽民12，刘佐军，[摘要]肿瘤的发病率逐年升高，而随若医疗条件及肿瘤诊治水平的提高，肿温宇梅瘤患者生存率也提高，但肿瘤治疗相关心脏毒性也逐步显现。对肿瘤幸存者来说，心血管疾病已成为危害生命健康的第二大杀手，仅次于复发性恶性肿瘤。而高血压是一种在肿瘤患者中发病率高又容易被忽视的心血管疾病。肿瘤相关[基金项目]北京市自然科学基金面上专高血压作为一个新兴的亚领域，其防治标准尚未统一。2022年8月欧洲心脏项(M22009)病学会(ESC)发布了第1个肿瘤心脏病学指南。本文从肿瘤相关高血压角度[作者简介]褚紫昕。女，住院医师。专出发，对肿瘤心脏病学指南进行解读。该指南明确了导致肿瘤相关高血压的肿业方向：肿箱心脏病学。E-mail:瘤治疗方案、定义了肿瘤相关高血压的治疗标准、提出了肿瘤相关高血压药物1124561667@qq.c0m.选择的原则并提供了肿瘤相关高血压监测和管理的建议，旨在帮助医疗专业人员对肿瘤相关高血压进行监测，以期减少心脏毒性，保证肿瘤治疗顺利进行，[通讯作者]国泽民，男，主任医师，专降低死亡率。业方向：高血压相关疾病精准医学研究以及临床转化、心血管慢病数字治疗、医学[关键词]肿瘤心脏病学肿瘤相关高血压血管内皮生长因子抑制剂血压管理：人工智能。E-mail:kzmkk@foxmail..指南解读come[中图分类号]R544.1[文献标志码]A[文章编号]2096-3327(2023)04-037-051首都医科大学附属北京路河医院医疗保健病D0110.3969/jissn.2096-3327.2023.04.005区，北京101100：2首都医科大学附属北京安贞医碗心内科高血压中心，北京100029[Abstract]The incidence of cancer is increasing year by year.With the improvemert of medical conditionsand the level of cancer diagnosis and treatment,the survival rate of cancer patients is also increasingbut the cardiotoxicity associated with cancer treatment has also gradually emerged.For cancer survivors,cardiovascular disease has become the second major killer,next to recurrent malignant tumors.Hyperensionis a cardiovascular disease with high incidence and easy to be ignored in cancer patients.Cancer-associatedhypertension is a new subfield and its prevention and treatment standards have not yet been standardized InAugust 2022,the European Society of Cardiology (ESC)issued the first guideline on cardio-oncdlogy.Thisarticle interprets the guideline on cardio-oncdlogy from the perspective of cancer-associated hypertension.The guideline clarifies the cancer treatment regimens leading to cancer-associated hypertension defines thetreatment standard for cancer-associated hypertension,proposes the principles of drug selection for cancer-associated hypertension,and provides recommendations for the monitoring and management of cancerassociated hypertension.The aim of this study is to help medical professionals to monitor cancer-associatedhypertension in order to reduce cardiotoxicity,ensure successful treatment of cancer,and reduce mortality.[Key words]cardio-oncology;dhypertension;vasur endothelial growth factor inhibitor,blood pressuemnagemguidinesinterprn肿瘤是人类死亡的首要原因，其发病率呈逐年上升趋势，在CHU Zi-xin',KUANG Ze-min,LIUZuo-jun',WEN Yu-mei2010~2015年间，我国肿瘤的发病率由235.23/10万人升至278.07/10万人。随着医疗条件的改善及肿瘤诊治水平的提高，肿瘤患者生存率提1Department of Health Care Ward,BeijingLuhe Hospital,Capital Medical University,高、生存期延长，但与此同时肿瘤治疗相关心脏毒性也逐步显现。对肿瘤Beijing 101100,China;2 Hypertension Center幸存者来说，心血管疾病已成为危害生命健康的第二大杀手，仅次于复of Department of Cardiology,Beijing Anzhen发性恶性肿瘤四。2022年8月，欧洲心脏病学会(European SocietyHospital,Capital Medical University,Beijing100029,Chinaof Cardiology,ESC)联合欧洲血液学协会(European Hematology(C)1994-2023 China Academic Journal Electronic Publishing House.All rights reserved.http:2in I 37
